Nirogy Therapeutics to Present at AACR Annual Meeting 2021
April 07, 2021 08:00 ET
|
Nirogy Therapeutics
BOSTON, April 07, 2021 (GLOBE NEWSWIRE) -- Nirogy Therapeutics Inc., a privately-held biotechnology company developing novel small molecules to target cellular transporters, today announced that the...
Nirogy Therapeutics Launches with $16.5 Million Series A Financing
January 26, 2021 08:00 ET
|
Nirogy Therapeutics
BOSTON, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Nirogy Therapeutics Inc., a privately-held biotechnology company developing novel small molecules to target cellular transporters, today announced the...